Clinical Trials Sponsored by Nerium Biotechnology

Total 1408 results

TWi Biotechnology, Inc.

Completed

A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy

Hemophilic Arthropathy

Taiwan
Lung Biotechnology PBC

Completed

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

Pulmonary Arterial Hypertension

United States, Ireland, Belgium
Unity Biotechnology, Inc.

Completed

A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
OrienGene Biotechnology Ltd.

Unknown

A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients

Melanoma (Skin)

China
Lung Biotechnology PBC

Completed

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Ireland
Golden Biotechnology Corporation

Completed

A Trial of Antroquinonol in Patients With Atopic Dermatitis

Atopic Dermatitis

Taiwan
Puma Biotechnology, Inc.

Completed

Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer (NEFERTT)

Breast Cancer

Spain, China, United States, Australia, Hong Kong, Malaysia, Korea, Republic of, Singapore, Belgium, Japan, India, France, Hungary, Romania, Italy, Bulgaria, Germany, Serbia, United Kingdom, South Africa, Canada, Israel, Taiwan, Switz... and more
Puma Biotechnology, Inc.

Completed

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Neoplasms | Breast Neoplasms

United States, Belgium, India, China, Russian Federation, Mexico, France
Puma Biotechnology, Inc.

Completed

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Breast Cancer | Advanced Malignant Solid Tumors

United States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
Puma Biotechnology, Inc.

Completed

Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer

HER2-mutant Non-Small Cell Lung Cancer

United States, France
Tamir Biotechnology, Inc.

Completed

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Sexually Transmitted Diseases | Papillomavirus Infections | Condylomata Acuminata

Bolivia
Cougar Biotechnology, Inc.

Completed

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (mCRPC)

Prostate Cancer | Prostate Neoplasms

United States
BRIM Biotechnology Inc.

Completed

Safety and Efficacy of BRM421 for Dry Eye Syndrome

Dry Eye Syndrome

United States
OrienGene Biotechnology Ltd.

Unknown

A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c

Melanoma

China
American International Biotechnology

Unknown

Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method (SAGE)

Vaginosis, Bacterial

United States
Golden Biotechnology Corporation

Completed

Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Taiwan
Tamir Biotechnology, Inc.

Withdrawn

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Cougar Biotechnology, Inc.

Completed

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Prostate Neoplasms

United States, United Kingdom
Cougar Biotechnology, Inc.

Completed

A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function

Prostate Cancer

United States
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis
Generex Biotechnology Corp.

No longer available

Treatment Use of Generex Oral-lyn™ in Patients With Diabetes

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus
Cougar Biotechnology, Inc.

Completed

A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers

Healthy Volunteers
Cougar Biotechnology, Inc.

Completed

A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function

Renal Insufficiency

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating The Tolerability Of Multiple Doses Of HKI-272

Healthy Subjects

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin

Healthy

United States
Lung Biotechnology PBC

Withdrawn

A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor

Pulmonary Arterial Hypertension
Puma Biotechnology, Inc.

Completed

HKI-272 Ketoconazole Drug Interaction Study

Healthy
Puma Biotechnology, Inc.

Completed

Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

Breast Cancer

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating Oral Administrations of HKI-272 in Healthy Male Subjects

Healthy
Cytos Biotechnology AG

Completed

Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany, Switzerland
Cytos Biotechnology AG

Completed

CYT003-QbG10 for Treatment of Allergic Asthma Bronchial

Allergic Bronchial Asthma

Germany
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Cytos Biotechnology AG

Completed

Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers

Smokers

Switzerland
Cytos Biotechnology AG

Completed

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Mild Essential Hypertension | Moderate Essential Hypertension

Switzerland
Cytos Biotechnology AG

Completed

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Perennial Allergy to House Dust Mite and/or Cat

Estonia, Latvia, Lithuania
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Hopstem Biotechnology Inc.

Recruiting

A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke

Chronic Ischemic Stroke

China
Accutar Biotechnology Inc

Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Relapsed/Refractory B-cell Malignancies

United States
BRIM Biotechnology Inc.

Recruiting

Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.

Dry Eye Disease

United States
TWi Biotechnology, Inc.

Recruiting

Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients With Granuloma Annulare

Granuloma Annulare

United States
Medigen Biotechnology Corporation

Recruiting

A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study

Colon Cancer Stage I

Taiwan
Healthgen Biotechnology Corp.

Recruiting

Study of OsrhAAT or Placebo in Healthy Volunteers

Emphysema Secondary to Congenital AATD

United States
Moat Biotechnology Corporation
Moat Biotechnology Corporation

Recruiting

A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers

Covid19

Australia
Healthgen Biotechnology Corp.

Recruiting

A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

Cirrhotic Ascites

China
Unity Biotechnology, Inc.

Completed

Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)

Diabetic Macular Edema (DME)

United States, Canada
Paean Biotechnology Inc.

Completed

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

Dermatomyositis | Polymyositis

Korea, Republic of
Puma Biotechnology, Inc.

Terminated

Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations (SUMMIT)

Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

France, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
Accutar Biotechnology Inc

Terminated

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Metastatic Castration Resistant Prostate Cancer

China
Golden Biotechnology Corporation

Completed

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

Covid-19

United States, Argentina, Peru
Golden Biotechnology Corporation

Completed

A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B

HBV

Taiwan

3

Subscribe